Obesity is a disease that affects about 13 % of the world population (2016) (Who 2018). This condition generates a process of systemic inflammation that may contribute to the release of cell-free DNA (cfDNA) into the bloodstream. cfDNA has been considered a potential biomarker to monitor several physiological and pathological conditions, such as tumors, exercise intensity and obesity. Therefore, the objective of this study was to evaluate the association of cfDNA levels with the amount of weight and fat mass lost six months after bariatric surgery. Thirty-eight subjects classified as obese (BMI, 43.5+/-6.2; BFP, 46.6+/-4.8) were evaluated anthropometrically and underwent bariatric surgery. Weight, BMI, body fat percentage (BFP), waist circumference, C-Reactive Protein (CRP) and cfDNA levels were evaluated before and six months after surgery; furthermore, a correlation was performed between cfDNA levels and BFP and CRP. Decrease in total body weight and CRP were observed after bariatric surgery; however, the cfDNA levels remained unchanged. There was a weak correlation between cfDNA levels and BFP before the bariatric surgery, and a moderate correlation between cfDNA and CRP. Obese subjects who underwent bariatric surgery, the decrease in body fat percentage did not result in changes in cfDNA levels six months after surgery.

Department of Physiological Sciences Health Sciences Center Federal University of Espírito Santo Vitória Brazil

Zobrazit více v PubMed

ALKHOURI N, GORNICKA A, BERK MP, THAPALIYA S, DIXON LJ, KASHYAP S, SCHAUER PR, FELDSTEIN AE. Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis. J Biol Chem. 2010;285:3428–3438. doi: 10.1074/jbc.m109.074252. PubMed DOI PMC

ANDREATTA MV, CURTY VM, COUTINHO JVS, SANTOS MÂA, VASSALLO PF, De SOUSA NF, BARAUNA VG. cfDNA as an earlier predictor of exercise-induced performance decrement related to muscle damage. Int J Sports Physiol Perform. 2017. pp. 1–14. PubMed DOI

BLÜHER M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15:288–298. doi: 10.1038/s41574-019-0176-8. PubMed DOI

BRAY GA. Etiology and pathogenesis of obesity. Clin Cornerstone. 1999;2:1–15. doi: 10.1016/s1098-3597(99)90001-7. PubMed DOI

DHURANDHAR EJ, KEITH SW. The etiology of obesity beyond eating more and exercising less. Best Pract Res Clin Gastroenterol. 2014;28:533–544. doi: 10.1016/j.bpg.2014.07.001. PubMed DOI

FERRANDI PJ, FICO BG, WHITEHURST M, ZOURDOS MC, BAO F, DODGE KM, RODRIGUEZ AL, PENA G, HUANG CJ. Acute high-intensity interval exercise induces comparable levels of circulating cell-free DNA and Interleukin-6 in obese and normal-weight individuals. Life Sci. 2018;202:161–166. doi: 10.1016/j.lfs.2018.04.007. PubMed DOI

HAGHIAC M, VORA NL, BASU S, JOHNSON KL, PRESLEY L, BIANCHI DW, HAUGUEL-De MOUZON S. Increased death of adipose cells, a path to release cell-free DNA into systemic circulation of obese women. Obesity (Silver Spring) 2012;20:2213–2219. doi: 10.1038/oby.2012.138. PubMed DOI PMC

HUBÁCEK JA. Eat less and exercise more - is it really enough to knock down the obesity pandemia? Physiol Res. 2009;58(Suppl 1):S1–S6. PubMed

KYLE UG, BOSAEUS I, De LORENZO AD, DEURENBERG P, ELIA M, MANUEL GÓMEZ J, LILIENTHAL HEITMANN B, KENT-SMITH L, MELCHIOR J-C, PIRLICH M, SCHARFETTER H, SCHOLS MWJA, PICHARD C, ESPEN Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr. 2004;23:1430–1453. doi: 10.1016/j.clnu.2004.09.012. PubMed DOI

LAGERROS YT, RÖSSNER S. Obesity management: what brings success? Therap Adv Gastroenterol. 2013;6:77–88. doi: 10.1177/1756283x12459413. PubMed DOI PMC

LEITE F, LEITE Â, SANTOS A, LIMA M, BARBOSA J, COSENTINO M, RIBEIRO L. Predictors of subclinical inflammatory obesity: plasma levels of leptin, very low-density lipoprotein cholesterol and CD14 expression of CD16+ monocytes. Obes Facts. 2017;10:308–322. doi: 10.1159/000464294. PubMed DOI PMC

De LORENZO A, SOLDATI L, SARLO F, CALVANI M, Di LORENZO N, Di RENZO L. New obesity classification criteria as a tool for bariatric surgery indication. World J Gastroenterol. 2016;22:681–703. doi: 10.3748/wjg.v22.i2.681. PubMed DOI PMC

McALLISTER EJ, DHURANDHAR NV, KEITH SW, ARONNE LJ, BARGER J, BASKIN M, BENCA RM, BIGGIO J, BOGGIANO MM, EISENMANN JC, ELOBEID M, FONTAINE KR, GLUCKMAN P, HANLON EC, KATZMARZYK P, PIETROBELLI A, REDDEN DT, RUDEN DM, WANG C, WATERLAND RA, WRIGHT SM, ALLISON DB. Ten putative contributors to the obesity epidemic. Crit Rev Food Sci Nutr. 2009;49:868–913. doi: 10.1080/10408390903372599. PubMed DOI PMC

NISHIMOTO S, FUKUDA D, HIGASHIKUNI Y, TANAKA K, HIRATA Y, MURATA C, KIM-KANEYAMA J, SATO F, BANDO M, YAGI S, SOEKI T, HAYASHI T, IMOTO I, SAKAUE H, SHIMABUKURO M, SATA M. Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance. Sci Adv. 2016;2:1–11. doi: 10.1126/sciadv.1501332. PubMed DOI PMC

PI-SUNYER FX. Obesity: criteria and classification. Proc Nutr Soc. 2000;59:505–509. doi: 10.1017/s0029665100000732. PubMed DOI

SANDQUIST M, WONG HR. Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment. Expert Rev Clin Immunol. 2014;10:1349–1356. doi: 10.1586/1744666X.2014.949675. PubMed DOI PMC

SCHMIDT MI, SAAD MJA, DUNCAN BB. Subclinical inflammation and obesity, diabetes and related disorders. Drug Discov Today Dis Mech. 2005;2:307–312. doi: 10.1016/j.ddmec.2005.08.003. DOI

VOLCKMAR AL, SÜLTMANN H, RIEDIGER A, FIORETOS T, SCHIRMACHER P, ENDRIS V, STENZINGER A, DIETZ S. A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications. Genes Chromosomes Cancer. 2018;57:123–139. doi: 10.1002/gcc.22517. PubMed DOI

WHO, World Health Organization. [accessed 22 March 2019];Obesity and overweight. 2018

XU Y, SONG Y, CHANG J, ZHOU X, QI Q, TIAN X, LI M, ZENG X, XU M, ZHANG W, CRAM DS, LIU J. High levels of circulating cell-free DNA are a biomarker of active SLE. Eur J Clin Invest. 2018;48:1–10. doi: 10.1111/eci.13015. PubMed DOI

Sex Difference in Plasma Deoxyribonuclease Activity in Rats